Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer

To apply a systems pathology-based approach to the quantification of nuclear Active β-catenin and human leukocyte antigen class I, and assess the biomarker involvement in a cohort of prostate tumor patients.

http://bit.ly/2UtIF3a